secwatch.observer — SEC 8-K summary
======================================

Issuer:     Accustem Sciences Inc. (ACUT)
CIK:        0001850767
Form:       8-K
Filed at:   2022-03-10T23:59:59+00:00
Accession:  0001493152-22-006524
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AccuStem Sciences appoints Wendy Blosser as CEO with $425k salary and options
-----------------------------------------------------------------------------

- Wendy Blosser appointed CEO effective March 4, 2022.
- Base salary of $425,000 per year; eligible for annual bonus of 45% of base, with $47,813 guaranteed in Q1 2022.
- Initial stock option award of 490,000 shares at $2.13 exercise price, subject to board approval.
- 50% of options vest over 4 years; 25% upon $30M equity fundraise; 25% upon CLIA lab launch by Q4 2023.
- Employment is at-will; offer contingent on background check and restrictive covenant agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850767/000149315222006524/0001493152-22-006524-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850767/000149315222006524/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-006524

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer